The case for population-based screening for colorectal cancer.
Screening for colorectal cancer is commanding increasing attention. Other cancer screening programmes have been a part of public consciousness for some time, but, until recently, colorectal cancer screening has remained in the background. Fuelled by new research, market opportunities and increased recognition of individual risk, screening for colorectal cancer is becoming a recommended procedure, but controversy about how best to implement widespread screening remains.
Schoen
Robert E
RE
Division of Gastroenterology, Pennsylvania University Hospital, Pittsburgh 15213-2582, USA. schoen@msx.dept-med.pitt.edu
D000236:Adenoma / Q000175:diagnosis / Q000453:epidemiology / Q000601:surgery; D018256:Adenomatous Polyps / Q000175:diagnosis / Q000453:epidemiology / Q000601:surgery; D000328:Adult; D000368:Aged; D017609:Barium Compounds; D014408:Biomarkers, Tumor / Q000032:analysis; D003111:Colonic Polyps / Q000175:diagnosis / Q000453:epidemiology / Q000601:surgery; D023881:Colonography, Computed Tomographic / Q000191:economics; D003113:Colonoscopy / Q000191:economics; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D018450:Disease Progression; D005243:Feces / Q000737:chemistry; D011905:Genes, ras; D006801:Humans; D007417:Intestinal Polyps / Q000175:diagnosis / Q000453:epidemiology / Q000601:surgery; D008403:Mass Screening / Q000191:economics / Q000379:methods; D008875:Middle Aged; D009780:Occult Blood; D010342:Patient Acceptance of Health Care; D010349:Patient Compliance; D011237:Predictive Value of Tests; D015397:Program Evaluation; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D012680:Sensitivity and Specificity; D012812:Sigmoidoscopy
D017609:Barium Compounds; D014408:Biomarkers, Tumor